NORTHBROOK, Ill., Oct. 2, 2025 /PRNewswire/ -- Endevica Bio, a clinical-stage biotechnology company pioneering peptide therapeutics for metabolic diseases, announced a major scientific breakthrough ...
Spurred by the discoveries of human pluripotent stem cell culture by James Thomson in the 1990s and the induction of pluripotency from adult cells by Shinya Yamanaka in the 2000s, therapeutics derived ...
Upstream Bio, Inc. (UPB) completed its IPO back in October 2024, raising approximately $293 million. This biotech is placing itself in a good position to do well because it is leveraging an entirely ...
OSSIO expands portfolio of highly differentiated bio-integrative fixation implants with small compression staples to enhance bunion repair patients’ satisfaction Revolutionary material science ...
Pleasanton, CA, Aug. 23, 2023 (GLOBE NEWSWIRE) -- Peak Bio, Inc. ("Peak Bio" or the "Company") (OTC PK: PKBO), is a clinical-stage biopharmaceutical company focused on developing the next-generation ...
AMSBIO (Oxford, UK) announces an innovative range of induced pluripotent stem cell (iPSC) kits for researchers requiring a rapid, reproducible, and scalable means of generating specific neural cell ...
– Data support the potential of verekitug’s unique mechanism of action to achieve a differentiated therapeutic effect across a broad range of TSLP-driven severe respiratory diseases – “We continue to ...
Rapid precision run-on sequencing (rPRO-seq) may help doctors understand disease states and treatment response in real time. Researchers at Sylvester Comprehensive Cancer Center (FL, USA) have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback